Siga Technologies INC Operating Lease, Liability, Current
Siga Technologies INC (SIGA) had Operating Lease, Liability, Current of $439.40 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $439.40K.
- 2026-03-31: Operating Lease, Liability, Current $538.23K.
- 2025-12-31: Operating Lease, Liability, Current $595.17K.
- 2025-09-30: Operating Lease, Liability, Current $582.67K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $439.40K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $538.23K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $595.17K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $582.67K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $570.43K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $558.65K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $546.82K 10-K · filed 2026-03-10 |
| 2024-09-30 | $535.23K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $523.89K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $503.47K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $564.01K 10-K · filed 2025-03-11 |
| 2020-09-30 | $441.99K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $434.13K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $427.06K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $419.71K 10-Q · filed 2020-11-05 |
| 2019-09-30 | $412.44K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $405.24K 10-Q · filed 2019-08-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |